4D Molecular Therapeutics Announces Proposed Public Offering

EMERYVILLE, Calif., May 04, 2023 -- 4D Molecular Therapeutics, Inc. , a clinical-stage biotherapeutics company harnessing the power of directed evolution for genetic medicines targeting large... | May 4, 2023

Related Keywords

North Carolina , United States , Charlotte , New York , Emeryville , Julian Pei , Katherine Smith , Exchange Commission , D Molecular Therapeutics Inc , Evercore Group , Drug Administration , Nasdaq , Securities Exchange , Goldman Sachs Co , Prospectus Department , Molecular Therapeutics , Bofa Securities , Goldman Sachs , Tryon Street , Equity Capital Markets , Therapeutic Vector Evolution , Securities Act , Securities Exchange Act , Molecular Therapeutic , Annual Report , Private Securities Litigation Reform Act , Investor Relations , 4d Molecular Therapeutics , Nc Stock Exchange , News , Information , Press Release , Bay , 023 , D , Olecular , Iotherapeutics , Company , Harnessing , The , Tower , F , Directed , Revolution , Or , Enetic , Medicines , Argeting Fdmt Us35104e1001 ,